Amoxycillin /Potassium Clavulanate 625 Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 500mg+125mg / 250mg+125mg
Reference Brands: Augmentin (USA/EU), Co-amoxiclav (UK)
Category:
Antibiotics
Amoxicillin Potassium CLavulanate Tablet is used to treat certain infections such as urinary tract infections which include inflammation of the kidney (pyelonephritis), and infection of the wall of the urinary bladder (cystitis), skin and skin structure infections such as serious bacterial skin infection (cellulitis), lower respiratory tract infections which include inflammation of the airways (bronchitis) or infection in the lungs (pneumonia).
Amoxycillin /Potassium Clavulanate 625 Tablets is available in Tablets
and strengths such as 500mg+125mg / 250mg+125mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amoxycillin /Potassium Clavulanate 625 Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amoxycillin /Potassium Clavulanate 625 Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amoxycillin / Potassium Clavulanate Tablets are a widely used combination antibiotic therapy designed to treat a broad range of bacterial infections. This formulation combines amoxicillin trihydrate, a penicillin-class antibiotic, with potassium clavulanate, a beta-lactamase inhibitor. Amoxicillin works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria, while clavulanate protects amoxicillin from degradation by beta-lactamase enzymes produced by resistant strains.
This combination significantly expands the spectrum of activity of amoxicillin, making it effective against both Gram-positive and Gram-negative bacteria, including those that would otherwise be resistant. It is commonly prescribed for respiratory tract infections such as sinusitis, bronchitis, and pneumonia, as well as urinary tract infections, skin and soft tissue infections, and dental infections.
Available in various tablet strengths, this medication is suitable for both outpatient and hospital use. Due to its broad-spectrum efficacy and well-established safety profile, it is one of the most commonly prescribed antibiotics worldwide, used under proper medical guidance to ensure optimal therapeutic outcomes and to minimize antibiotic resistance.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing